ENAVO-AF: Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation (clinicaltrials.gov) - May 13, 2026 - P4 | N=390 | Recruiting | Sponsor: Yonsei University | Trial completion date: Aug 2026 ➔ May 2027 | Trial primary completion date: Aug 2026 ➔ May 2027 | Not yet recruiting ➔ Recruiting
Enrollment open • Trial completion date • Trial primary completion date • Atrial Fibrillation • Cardiovascular • Congestive Heart Failure • Heart Failure
|